Research
Overview
Research in our group is centered on the development of innovative diagnostic and therapeutic technologies, with a particular emphasis on creating solutions that are accessible and effective in low-resource settings. Our key focus areas include:
Subdermal Wearable Biosensors: We are developing minimally invasive sensors designed for continuous monitoring of physiological and biochemical markers in real-time. These devices are tailored for applications in personalized healthcare, with a special focus on making them affordable and practical for use in low-resource environments.
Point-of-Care Devices: Our work in point-of-care diagnostics is aimed at creating portable, low-cost devices that deliver rapid and accurate results. These technologies are being developed for a range of applications, including clinical diagnostics, remote healthcare, and public health monitoring, particularly in settings where resources are limited.
Electrochemical Biosensors: We are designing and fabricating electrochemical biosensors that utilize various bioreceptors, including enzymes, aptamers, and peptide receptors. These sensors are optimized for the detection of critical biomolecules, such as glucose and pathogens, with applications in both clinical and environmental contexts, and are being developed with cost-effectiveness in mind.
Microfluidic Diagnostics and Lab-on-a-Chip: Our research includes the integration of microfluidic systems with biosensing technologies to create compact, efficient diagnostic devices. These lab-on-a-chip platforms enable multiplexed testing and are designed to be affordable and accessible, offering powerful tools for rapid and high-throughput analysis in both clinical and research environments.
Transdermal and Intradermal Therapeutic Delivery: We are innovating in the field of drug and vaccine delivery by developing microneedle-based devices for transdermal and intradermal administration. These technologies aim to improve patient comfort and adherence while ensuring cost-effectiveness for broader implementation, especially in resource-constrained areas.
Multiplexed Ultrasensitive Point-of-Care Testing: Our team is advancing the capabilities of point-of-care testing through the development of multiplexed assays that can detect multiple analytes simultaneously with high sensitivity. This approach is key to enhancing the diagnostic power and efficiency of point-of-care devices, with an emphasis on affordability and scalability for widespread use.
Research grants
"Multi-analyte prognostic and diagnostic screening in blood and skin for Alzheimer's disease"
MEDICAL RESEARCH COUNCIL
June 2024 - February 2026